7.1 C
New York
Friday, April 19, 2024

Jazz Pharmaceuticals Up On Allergan, Inc. Rumor

Courtesy of Benzinga.

Related JAZZ
Dow Flirts With 19,000, S&P 500 Approaches 2,000 & NASDAQ Trading At 14-Year Highs
JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth And Acquisition'

Citing three industry bankers, dealReporter is saying that If Allergan, Inc. was looking for a defensive deal, Jazz Pharmaceuticals (NASDAQ: JAZZ) would likely be most viable target.

Shares of Jazz, which have been the subject of much speculation lately, are getting a big lift on the news, trading higher by 6.8 percent at $167.64. Allergan is also higher by 0.78 percent at $166.80.

Posted-In: News Rumors

1 COMMENT

Subscribe
Notify of
1 Comment
Inline Feedbacks
View all comments

Stay Connected

157,353FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

1
0
Would love your thoughts, please comment.x
()
x